RTP Pharma, SkyePharma deal

SKP acquired the remaining 59.8% of RTP it did not already own for $20.6 million in stock. Last year, SKP acquired a 40.2% stake in RTP for 17.3 million SKP shares valued at $20 million, plus $5 milli...